|
59
|
226
|
4qvnH |
Ycp beta5-m45v mutant in complex with bortezomib |
|
70
|
243
|
4qv4F |
Ycp beta5-m45t mutant |
|
57
|
233
|
4r67B |
Human constitutive 20s proteasome in complex with carfilzomib |
|
61
|
195
|
4qz2J |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
62
|
231
|
4qwkE |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
73
|
240
|
4qvvC |
Ycp beta5-a49v mutant in complex with bortezomib |
|
63
|
231
|
4qv3E |
Ycp beta5-m45v mutant |
|
66
|
212
|
4qwuK |
Ycp beta5-c52f mutant in complex with bortezomib |
|
66
|
242
|
4qw5D |
Ycp beta5-m45a mutant in complex with carfilzomib |
|
70
|
243
|
4qv8F |
Ycp beta5-c52f mutant |
|
70
|
212
|
4qwxK |
Ycp in complex with the epoxyketone inhibitor onx 0914 |
|
69
|
244
|
4qw3B |
Ycp beta5-c63f mutant in complex with bortezomib |
|
72
|
240
|
4qv7C |
Ycp beta5-a50v mutant |
|
61
|
241
|
4r00G |
Ycp beta5-c52f mutant in complex with omuralide |
|
61
|
195
|
4qvqJ |
Ycp beta5-m45i mutant in complex with bortezomib |
|
56
|
204
|
4r00I |
Ycp beta5-c52f mutant in complex with omuralide |
|
71
|
212
|
4qz3K |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
243
|
4qv1F |
Ycp beta5-m45a mutant |
|
68
|
244
|
4r17B |
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20s proteasome |
|
62
|
195
|
4qz3J |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
62
|
241
|
4qw0G |
Ycp beta5-a49t-a50v-double mutant in complex with bortezomib |
|
57
|
222
|
4qz5H |
Ycp beta5-a49t-mutant in complex with onx 0914 |
|
71
|
212
|
4qwiK |
Ycp beta5-a49s-mutant in complex with carfilzomib |
|
69
|
250
|
4qv9A |
Ycp beta5-c63f mutant |
|
71
|
243
|
4qz7F |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
58
|
222
|
4qwiH |
Ycp beta5-a49s-mutant in complex with carfilzomib |
|
67
|
250
|
4qv5A |
Ycp beta5-m45i mutant |
|
62
|
195
|
4qzwJ |
Ycp beta5-c52f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
62
|
241
|
4qz1G |
Ycp beta5-m45t mutant in complex with the epoxyketone inhibitor onx 0914 |
|
69
|
250
|
4qw4A |
Ycp in complex with carfilzomib |
|
71
|
250
|
4quyA |
Ycp beta5-a49s-mutant |
|
60
|
231
|
4r02E |
Ycp in complex with bsc4999 (alpha-keto phenylamide) |
|
61
|
195
|
4qz1J |
Ycp beta5-m45t mutant in complex with the epoxyketone inhibitor onx 0914 |
|
63
|
231
|
4qwjE |
Ycp beta5-a49t-mutant in complex with carfilzomib |
|
67
|
250
|
4qvpA |
Ycp beta5-m45t mutant in complex with bortezomib |
|
58
|
204
|
4qv3I |
Ycp beta5-m45v mutant |
|
61
|
195
|
4r18J |
Ligand-induced lys33-thr1 crosslinking at subunit beta5 of the yeast 20s proteasome |
|
63
|
241
|
4qz4G |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
212
|
4qwkK |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
69
|
233
|
4qw0M |
Ycp beta5-a49t-a50v-double mutant in complex with bortezomib |
|
65
|
240
|
4qwgC |
Ycp beta5-a49v mutant in complex with carfilzomib |
|
60
|
196
|
4qz6N |
Ycp beta5-a49t-a50v double mutant in complex with the epoxyketone inhibitor onx 0914 |
|
61
|
222
|
4qlqL |
Ycp in complex with tripeptidic epoxyketone inhibitor 8 |
|
61
|
195
|
4qz0J |
Ycp beta5-m45v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
68
|
240
|
4qw4C |
Ycp in complex with carfilzomib |
|
60
|
195
|
4qvnJ |
Ycp beta5-m45v mutant in complex with bortezomib |
|
68
|
240
|
4qz3C |
Ycp beta5-a49v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
65
|
242
|
4qwgD |
Ycp beta5-a49v mutant in complex with carfilzomib |
|
59
|
196
|
4r17N |
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20s proteasome |
|
72
|
243
|
4qz5F |
Ycp beta5-a49t-mutant in complex with onx 0914 |
